Microgentas
PrivateLast Round
Seed
Jan 1, 2021
Company Overview
Microgentas operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Seed round in January 2021.
Microgentas is a biotechnology company that develops exosome isolation and purification technologies, including diagnostic kits and research reagents for liquid biopsy and in vitro diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Microgentas Comparables
Compare Microgentas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellBio Scientific | 78% | |
| Lonza Group | 78% | |
| Fujifilm Holdings Corporation | 72% |
For institutional investors. Book with your work email.
Microgentas Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Microgentas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea University Holdings | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2025
Monthly visitors increased 31% MoM, reaching 1.7K.
- Jan 1, 2021
Seed round led by Korea University Holdings.
For institutional investors. Book with your work email.
Microgentas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Microgentas's valuation, stock price, and market status.
Is Microgentas a public or private company?
Microgentas is a private company.
What is the current stock price of Microgentas?
Microgentas is a private company, so its shares have no public market price. Caplight tracks Microgentas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Microgentas worth (valuation)?
Valuation information for Microgentas is not publicly available.
Can I buy Microgentas stock?
Microgentas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Microgentas's last funding round?
Microgentas's most recent funding round was Seed on January 1, 2021.
Who are the main investors in Microgentas?
Key investors in Microgentas include Korea University Holdings.
Will Microgentas IPO soon?
No public IPO plans have been announced for Microgentas.
How can I track Microgentas secondary market activity?
Caplight tracks bids, offers, and trades in Microgentas's shares on secondary markets.